The effect of folic acid on the homocysteine metabolism in human umbilical vein endothelial cells (HUVECs)

Mild hyperhomocysteinaemia is associated with increased risk for vascular disease. We studied homocysteine export from human umbilical vein endothelial cells (HUVECs) by measuring total homocysteine (tHcy) concentrations in the culture medium. Under standard culture conditions tHcy concentrations in the HUVEC culture medium increased by constant amounts after 24, 48 and 72 h [mean = 2.5 (SD ± 0.7) μmol L−1 homocysteine every 24 h]. As the cells are the only source of homocysteine increase in the culture medium, we designate this as homocysteine export from HUVEC. Folic acid supplementation to the culture medium lowered the homocysteine export in a dose‐dependent manner. Methyl‐tetrahydrofolate (MeTHF) and folinic acid (a stable precursor of MeTHF) were in this respect about 10 times more effective than folic acid. A 50% reduction in the homocysteine export was seen with 10–30 nmol L−1 MeTHF supplementation; reduction to almost zero was seen with 100–300 nmol L−1 MeTHF. Additions to the culture medium of the other vitamins involved in the homocysteine metabolism, such as vitamin B12, vitamin B6 and flavin adenine dinucleotide, did not show any effect on homocysteine export. Because homocysteine export reflects an imbalance in the homocysteine metabolism, our observations showed a susceptible dependency of this metabolism on folic acid in endothelial cells.

[1]  H. Blom,et al.  Three Different Methods for the Determination of Total Homocysteine in Plasma , 1995, Annals of clinical biochemistry.

[2]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[3]  H. Blom,et al.  Treatment of mild hyperhomocysteinemia in vascular disease patients. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  H. Blom,et al.  Pathobiochemical implications of hyperhomocysteinemia , 1994 .

[5]  P. Ueland,et al.  Effect of Methionine and Nitrous Oxide on Homocysteine Export and Remethylation in Fibroblasts from Cystathionine Synthase-Deficient, cblG, and cblE Patients , 1994, Pediatric Research.

[6]  H. Blom,et al.  Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. , 1993, Fertility and sterility.

[7]  K. Shimada,et al.  Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. , 1993, The Journal of clinical investigation.

[8]  P. Ueland,et al.  Total homocysteine in plasma or serum: methods and clinical applications. , 1993, Clinical chemistry.

[9]  K. Hajjar Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. , 1993, The Journal of clinical investigation.

[10]  D. Wilcken,et al.  Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to development of arteriosclerosis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  J. Sadler,et al.  Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. , 1993, Blood.

[12]  P. Ueland,et al.  Homocysteine and other thiols in plasma and urine: automated determination and sample stability. , 1993, Clinical chemistry.

[13]  D. Wilcken,et al.  Homocysteine catabolism: levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease. , 1992, Atherosclerosis.

[14]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[15]  P. Ueland,et al.  Homocysteine remethylation during nitrous oxide exposure of cells cultured in media containing various concentrations of folates. , 1992, The Journal of pharmacology and experimental therapeutics.

[16]  R. Steegers-Theunissen,et al.  Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae , 1992, The Lancet.

[17]  R. Francis Atherosclerotic cardiovascular disease, hemostasis, and endothelial function , 1992 .

[18]  W. Doesburg,et al.  Multivitamin supplementation in oral contraceptive users. , 1991, Contraception.

[19]  P. Ueland,et al.  Interaction between methotrexate, "rescue" agents and cell proliferation as modulators of homocysteine export from cells in culture. , 1991, The Journal of pharmacology and experimental therapeutics.

[20]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[21]  J. Finkelstein,et al.  Methionine metabolism in mammals. , 1990, The Journal of nutritional biochemistry.

[22]  G. Rodgers,et al.  Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. , 1990, Blood.

[23]  B. Norrving,et al.  Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. , 1990, Atherosclerosis.

[24]  D. Rosenblatt Inherited disorders of folate transport and metabolism , 1989 .

[25]  G. Starkebaum,et al.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. , 1986, The Journal of clinical investigation.

[26]  K. Pettigrew,et al.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency. , 1985, American journal of human genetics.

[27]  T. Maciag,et al.  An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[29]  G. Ehrlich,et al.  The Metabolic Basis Of Inherited Disease. , 1973 .

[30]  A. George The metabolic basis of inherited disease , 1961 .

[31]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.